The Pulmonary Fibrosis Foundation (PFF), the nation's leading pulmonary fibrosis (PF) research, education and advocacy ...
Un estudio clínico ha demostrado que la fibrosis en los tumores de mama HER2 negativos empeora el pronóstico de la enfermedad ...
Los tratamientos que existen no detienen su progresión, por lo que expertos en el tema conversaron sobre la búsqueda de terapias que puedan ayudar en el proceso.
El Hospital Clínico San Carlos ha desarrollado una aplicación llamada 'MyFibroPul' para mejorar la adherencia al tratamiento ...
Survival rates for idiopathic pulmonary fibrosis are worse than all solid cancers except for lung and pancreatic cancer. | ...
High-dose LTI-03 (5 mg BID), a Caveolin-1 related peptide, reduced expression of multiple profibrotic proteins in both ...
En medio de la tormenta mediática por las acusaciones de abuso contra su hijo, la esposa del Príncipe Haakon se ha desplazado ...
Aileron Therapeutics' Phase 1b trial shows LTI-03 improved biomarkers and reduced SPD levels, indicating the potential to ...
(RTTNews) - Aileron Therapeutics, Inc. (ALRN), Wednesday announced positive topline data from the cohort 2 of Phase 1b study evaluating LTI-03 in patients with idiopathic pulmonary fibrosis (IPF).
As physicians we take an oath to do no harm, yet are trapped providing care in a system that leaves patients confined and at ...
Sino-American firm Insilico Medicine has shown the potential not just of its pipeline and lead candidate by presenting ...
Last patient completed pivotal Phase 3 trial in CHB-associated liver fibrosis in the PRC with data expected in Q1 2025On track to initiate U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback